220 related articles for article (PubMed ID: 30913090)
21. Validation of a Modified Substaging System (Kinki Criteria) for Patients with Intermediate-Stage Hepatocellular Carcinoma.
Arizumi T; Ueshima K; Iwanishi M; Minami T; Chishina H; Kono M; Takita M; Kitai S; Inoue T; Yada N; Hagiwara S; Ida H; Minami Y; Sakurai T; Kitano M; Nishida N; Kudo M
Oncology; 2015; 89 Suppl 2():47-52. PubMed ID: 26584036
[TBL] [Abstract][Full Text] [Related]
22. Appraisal of a Model to Estimate Survival in Ambulatory Patients with Hepatocellular Carcinoma Classified as Barcelona Clinic Liver Cancer Stage B.
Yoo JJ; Yu SJ; Lee B; Cho EJ; Lee JH; Kim SG; Kim YJ; Kim YS; Yoon JH
Gut Liver; 2020 May; 14(3):377-386. PubMed ID: 31533399
[TBL] [Abstract][Full Text] [Related]
23. NIACE score for hepatocellular carcinoma patients treated by surgery or transarterial chemoembolization.
Adhoute X; Pénaranda G; Raoul JL; Bollon E; Pol B; Letreut YP; Perrier H; Bayle O; Monnet O; Beaurain P; Muller C; Hardwigsen J; Lefolgoc G; Castellani P; Bronowicki JP; Bourlière M
Eur J Gastroenterol Hepatol; 2017 Jun; 29(6):706-715. PubMed ID: 28195873
[TBL] [Abstract][Full Text] [Related]
24. Validation of The Hong Kong Liver Cancer Staging System in Patients with Hepatocellular Carcinoma after Curative Intent Treatment.
Chuncharunee A; Siramolpiwat S
Asian Pac J Cancer Prev; 2017 Jun; 18(6):1697-1701. PubMed ID: 28670891
[TBL] [Abstract][Full Text] [Related]
25. Application of the Intermediate-Stage Subclassification to Patients With Untreated Hepatocellular Carcinoma.
Giannini EG; Moscatelli A; Pellegatta G; Vitale A; Farinati F; Ciccarese F; Piscaglia F; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Borzio F; Cabibbo G; Felder M; Sacco R; Morisco F; Missale G; Foschi FG; Gasbarrini A; Baroni GS; Virdone R; Masotto A; Trevisani F; ;
Am J Gastroenterol; 2016 Jan; 111(1):70-7. PubMed ID: 26729544
[TBL] [Abstract][Full Text] [Related]
26. Barcelona clinic liver cancer-stage C hepatocellular carcinoma: A novel approach to subclassification and treatment.
Jun CH; Yoon JH; Cho E; Shin SS; Cho SB; Kim HJ; Park CH; Kim HS; Choi SK; Rew JS
Medicine (Baltimore); 2017 Apr; 96(17):e6745. PubMed ID: 28445298
[TBL] [Abstract][Full Text] [Related]
27. Evaluating the Ability of the New Subclassification to Prognosticate Outcomes Following Hepatectomy for Patients with HBV-Related HCC.
Tian Y; Lyu H; He Y; Kanduri HK
J Gastrointest Cancer; 2019 Sep; 50(3):400-407. PubMed ID: 29512001
[TBL] [Abstract][Full Text] [Related]
28. Hepatic Resection Provides Survival Benefit for Selected Intermediate-Stage (BCLC-B) Hepatocellular Carcinoma Patients.
Zhaohui Z; Shunli S; Bin C; Shaoqiang L; Yunpeng H; Ming K; Lijian L; Gang PB
Cancer Res Treat; 2019 Jan; 51(1):65-72. PubMed ID: 29510616
[TBL] [Abstract][Full Text] [Related]
29. Validity of the Barcelona Clinic Liver Cancer and Hong Kong Liver Cancer staging systems for hepatocellular carcinoma in Singapore.
Selby LK; Tay RX; Woon WW; Low JK; Bei W; Shelat VG; Pang TC; Junnarkar SP
J Hepatobiliary Pancreat Sci; 2017 Mar; 24(3):143-152. PubMed ID: 28012284
[TBL] [Abstract][Full Text] [Related]
30. Validation of Kinki Criteria, a Modified Substaging System, in Patients with Intermediate Stage Hepatocellular Carcinoma.
Arizumi T; Ueshima K; Iwanishi M; Minami T; Chishina H; Kono M; Takita M; Kitai S; Inoue T; Yada N; Hagiwara S; Minami Y; Ida H; Sakurai T; Kitano M; Nishida N; Kudo M
Dig Dis; 2016; 34(6):671-678. PubMed ID: 27750236
[TBL] [Abstract][Full Text] [Related]
31. Subclassification of BCLC B Stage Hepatocellular Carcinoma and Treatment Strategies: Proposal of Modified Bolondi's Subclassification (Kinki Criteria).
Kudo M; Arizumi T; Ueshima K; Sakurai T; Kitano M; Nishida N
Dig Dis; 2015 Oct; 33(6):751-8. PubMed ID: 26488473
[TBL] [Abstract][Full Text] [Related]
32. Transcatheter Arterial Chemoembolization With or Without Radiofrequency Ablation: Outcomes in Patients With Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma.
Hirooka M; Hiraoka A; Ochi H; Kisaka Y; Joko K; Michitaka K; Hiasa Y
AJR Am J Roentgenol; 2018 Apr; 210(4):891-898. PubMed ID: 29412017
[TBL] [Abstract][Full Text] [Related]
33. Impact of Tumor Factors on Survival in Patients with Hepatocellular Carcinoma Classified Based on Kinki Criteria Stage B2.
Arizumi T; Minami T; Chishina H; Kono M; Takita M; Yada N; Hagiwara S; Minami Y; Ida H; Ueshima K; Kamata K; Minaga K; Komeda Y; Takenaka M; Sakurai T; Watanabe T; Nishida N; Kudo M
Dig Dis; 2017; 35(6):583-588. PubMed ID: 29040991
[TBL] [Abstract][Full Text] [Related]
34. Validation and modification of a proposed substaging system for patients with intermediate hepatocellular carcinoma.
Wang JH; Kee KM; Lin CY; Hung CH; Chen CH; Lee CM; Lu SN
J Gastroenterol Hepatol; 2015 Feb; 30(2):358-63. PubMed ID: 25088668
[TBL] [Abstract][Full Text] [Related]
35. Subclassification of patients with intermediate-stage (Barcelona Clinic Liver Cancer stage-B) hepatocellular carcinoma using the up-to-seven criteria and serum tumor markers.
Kimura H; Ohkawa K; Miyazaki M; Sakakibara M; Imanaka K; Tamura T; Sueyoshi H; Takada R; Fukutake N; Uehara H; Ashida R; Ioka T; Nakazawa T; Nakanishi K; Katayama K
Hepatol Int; 2017 Jan; 11(1):105-114. PubMed ID: 27766479
[TBL] [Abstract][Full Text] [Related]
36. Significance of liver resection for intermediate stage hepatocellular carcinoma according to subclassification.
Yamamoto M; Kobayashi T; Hashimoto M; Kuroda S; Kawaoka T; Aikata H; Chayama K; Ohdan H
BMC Cancer; 2021 Jun; 21(1):668. PubMed ID: 34090354
[TBL] [Abstract][Full Text] [Related]
37. The Prognostic Ability of Major Hepatocellular Carcinoma Staging Systems Is Improved by Including a Treatment Variable.
Wallace MC; Knuiman M; Huang Y; Garas G; Adams LA; MacQuillan G; Preen DB; Jeffrey GP
Dig Dis Sci; 2018 Sep; 63(9):2277-2284. PubMed ID: 29808245
[TBL] [Abstract][Full Text] [Related]
38. Intermediate-advanced hepatocellular carcinoma in Argentina: Treatment and survival analysis.
Piñero F; Marciano S; Fernández N; Silva J; Anders M; Zerega A; Ridruejo E; Romero G; Ameigeiras B; D'Amico C; Gaite L; Bermúdez C; Reggiardo V; Colombato L; Gadano A; Silva M
World J Gastroenterol; 2019 Jul; 25(27):3607-3618. PubMed ID: 31367160
[TBL] [Abstract][Full Text] [Related]
39. Treatment allocation in hepatocellular carcinoma: Assessment of the BCLC algorithm.
Richani M; Kolly P; Knoepfli M; Herrmann E; Zweifel M; von Tengg-Kobligk H; Candinas D; Dufour JF
Ann Hepatol; 2016; 15(1):82-90. PubMed ID: 26626644
[TBL] [Abstract][Full Text] [Related]
40. Transarterial Chemoembolization versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Resection within Barcelona Clinic Liver Cancer Stage 0/A: A Retrospective Comparative Study.
Chen R; Gan Y; Ge N; Chen Y; Wang Y; Zhang B; Wang Y; Ye S; Ren Z
J Vasc Interv Radiol; 2016 Dec; 27(12):1829-1836. PubMed ID: 27553917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]